Navigation Links
BioElectronics Launches '1 Day Breast Augmentation Recovery Kit'
Date:3/13/2008

Meets the Growing Demand for Quicker Surgical Recoveries

FREDERICK, Md., March 13 /PRNewswire-FirstCall/ -- BioElectronics Corporation (BIEL) announces the product launch of its Breast Recovery Kit, for the relief of edema and post operative discomfort.

Developed by Dr. Barry Eppley, MD, DMD, the 1 Day Breast Recovery Kit allows breast surgery patients to return to their active lives the day after surgery. Using the patented technology, ActiPatch relieves edema and discomfort without drugs, ice, or topical ointments. Priced below $50.00 it is an excellent alternative to pain pumps, which pose a risk of infection, or oral analgesics and anti-inflammatory medications -- which many patients prefer not to take or cannot tolerate.

Dr. Barry L. Eppley is an extensively trained and unique plastic surgeon. Dr. Eppley received a Doctor of Medicine degree from Washington University in St. Louis as well as a Doctor of Dental Medicine degree from the University of Pennsylvania in Philadelphia. Dr. Eppley completed training in Oral and Maxillofacial Surgery at Barnes Hospital and St. John's Mercy Medical Center Hospital while in St. Louis. He furthered his training in General Surgery, Craniofacial and Cleft Surgery as well as full training in Plastic and Reconstructive Surgery at Indiana University. As a result of this education, Dr. Eppley is both a licensed physician and dentist and board certified in the specialties of Plastic and Reconstructive Surgery as well as Oral and Maxillofacial Surgery. This background brings a diverse experience and perspective to the requirements needed for facial plastic, craniofacial and maxillofacial, and cosmetic body contouring surgeries. For more visit: http://www.dreppley.com.

"We are thrilled and quite fortunate to have such a talented surgeon and educator as Dr. Eppley assisting in our product development. We look forward to his insight and help in our mission to change the way people heal," said BioElectronics' President Andrew Whelan.

ActiPatch(TM) is a drug-free, anti-inflammatory patch with an embedded battery operated microchip that delivers weeks of continuous pulsed therapy for less than a dollar a day. The unique ActiPatch(TM) delivery system, using patented technology, provides a cost-effective, patient friendly method to reduce soft tissue pain and swelling.

ActiPatch has regulatory clearance by the FDA for the treatment of edema following blepharoplasty.

For more information visit http://www.bioelectronicscorp.com or call 866-757-2284.


'/>"/>
SOURCE BioElectronics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. BioElectronics Corporation Announces Singapore and Malaysia Sales
2. BioElectronics Corporation Announces Distribution Agreement With TSS Medical of Italy
3. BioElectronics Announces Canadian Retail Product Launch
4. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
5. Novozymes Launches Enzyme to Reduce Acrylamide in Food
6. Enova Medical Launches Exos Corporation
7. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
8. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
9. ThirdBiotech Networking Group Launches
10. BioReliance Launches Next-Generation Genotoxicity Screening Service
11. Midwest Research Institute Launches Center for Biological Safety and Security (CBS2)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)... ... 12, 2017 , ... MEXICO’S FIRST SPINAL ... announces the successful outcome of the first lumbar fusion procedure in Mexico ... Inc.) has partnered with Mexico-based medical product company BioMedical Technologies to bring ...
(Date:1/12/2017)... , January 12, 2017 The ... world,s biggest facility for producing mycorrhizae. The Centre for ... tapping potential of mycorrhizae and developed a technology that ... ... The TERI facility has a ...
(Date:1/11/2017)... ... January 11, 2017 , ... Phase 1 clinical ... promise of the investigational anti-cancer agent tucatinib (formerly ONT-380) against HER2+ breast cancer. ... Twenty-seven percent of these heavily pretreated patients saw clinical benefit from the drug, ...
(Date:1/11/2017)... ... January 11, 2017 , ... With sepsis ... systems more than $23.7 billion, healthcare systems are looking to provide better ... most common sepsis-causing pathogens are bacteria and the yeast pathogen Candida, which can ...
Breaking Biology Technology:
(Date:12/20/2016)... -- The rising popularity of mobility services such ... significant interest in keyless access systems. Following the ... (BLE), biometrics and near-field communication (NFC) are poised ... technologies in the automotive industry. This evolution from ... opens the market to specialist companies such as ...
(Date:12/16/2016)... Dec. 16, 2016   IdentyTechSolutions America LLC ... products and solutions and a cutting-edge manufacturer of ... it is offering seamless, integrated solutions that comprise ... products. The solutions provide IdentyTech,s customers with combined ... facilities from crime and theft. "We ...
(Date:12/15/2016)... VANCOUVER, Canada and BADEN-BADEN, Germany ... Solutions, a leading global financial services provider, today announced an ... in passive behavioural biometrics, to join forces. The partnership will ... fraud mitigation strategies in compliance with local data protection regulation. ... In ...
Breaking Biology News(10 mins):